CIMZIA is indicated to treat active non-radiographic axial spondyloarthritis (nr-axSpA) with measures of inflammation.
IMPORTANT SAFETY INFORMATION: CIMZIAcan lower the ability of your immune system to fight infections. Some people who received CIMZIA have developed serious infections, including tuberculosis (TB) and infections caused by viruses, fungi, or bacteria that have spread throughout the body. Some of these serious infections have caused hospitalization and death. Click to open full Prescribing Information.